Overview

Pharmacogenetic Factors and Side Effects of Metoclopramide and Diphenhydramine

Status:
Terminated
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
Pharmacokinetic of Metoclopramide (MCP) in correlation to polymorphisms of CYP2D6 and Dopamine-D2-Receptor. Pharmacokinetic of Diphenhydramine (DPH) in correlation to polymorphisms of CYP2D6
Phase:
Phase 1
Details
Lead Sponsor:
Matthias Schwab
Treatments:
Diphenhydramine
Metoclopramide
Promethazine